Assessment of Esophageal Epithelium Integrity With Mucosal Impedance
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Gastroesophageal Reflux Disease |
| Therapuetic Areas: | Gastroenterology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/21/2016 |
| Start Date: | July 2013 |
| End Date: | December 2016 |
Gastroesophageal reflux disease (GERD) is a common condition affecting more than 100 million
adults in the U.S., and it significantly impacts patients' quality of life while imposing
billions of dollars of direct and indirect costs each year upon our healthcare system.
Current diagnostic tests for GERD are highly invasive and medically inadequate, and the goal
of this project is to develop a novel, minimally invasive Mucosal Impedance technique for
more accurate detection of GERD while reducing costs.
adults in the U.S., and it significantly impacts patients' quality of life while imposing
billions of dollars of direct and indirect costs each year upon our healthcare system.
Current diagnostic tests for GERD are highly invasive and medically inadequate, and the goal
of this project is to develop a novel, minimally invasive Mucosal Impedance technique for
more accurate detection of GERD while reducing costs.
Inclusion Criteria:
- Patients undergoing standard of care EGD with 48-hr pH testing by BRAVO
- Previous diagnosis of reflux
- At least 18 years of age
Exclusion Criteria:
- Those less than 18 years of age
- Unable to give informed consent
- Use of acid suppressive therapy within the last 10 days
- Known history of Barrett's esophagus, gastric surgery, alcoholism, or significant
motility condition
We found this trial at
1
site
1211 Medical Center Dr
Nashville, Tennessee 37232
Nashville, Tennessee 37232
(615) 322-5000
Vanderbilt Univ Med Ctr Vanderbilt University Medical Center (VUMC) is a comprehensive healthcare facility dedicated...
Click here to add this to my saved trials
